v1
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Identifier:nobleid.org/w1/20260515/B672CCFD
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/B672CCFD)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →